Agenus posted on LinkedIn:
“Our Chief Medical Officer Dr. Steven O’Day explains how new evaluation methods are helping to better capture the impact of immunotherapy and what this means for people living with historically hard-to-treat tumors, like Colorectal Cancer.
Read more from STAT here.”
Video attached to the post.